By Rick Archer ( April 29, 2019, 8:07 PM EDT) -- A Washington, D.C.-based consumer advocacy group asked a federal court on Monday to force the U.S. Food and Drug Administration to act on its 2016 petition saying dopamine agonist drugs should have a black-box warning about side effects that can cause compulsive behavior....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.